tiprankstipranks
Trending News
More News >
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market

TScan Therapeutics (TCRX) Revenue

Compare
313 Followers

TScan Therapeutics Revenue

TScan Therapeutics had a revenue of 2.51M in the quarter ending Sep 30, 2025, with -18.37%. This bring the company's revenue in the last twelve months to 8.42M, Decreased 21.00%. In the fiscal year ending Dec 31, 2024, TScan Therapeutics had annual revenue of 2.82M with -86.62% growth.
Revenue (ttm)
8.42M
Revenue Growth
-10.03%
P/S Ratio
19.37
Revenue/Employee
$14,080
Employees
200
Market Cap
$54.56M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.82M-18.23M+13.38%
Dec 31, 2023
21.05M7.51M+155.52%
Dec 31, 2022
13.54M3.39M+133.47%
Dec 31, 2021
10.14M9.06M+934.66%
Dec 31, 2020
1.08M-108,500,000.00%
Dec 31, 2019